GALECTIN THERAPEUTICS INC (GALT) Common Stock, Shares Authorized 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Galectin Therapeutics Inc quarterly Common Stock, Shares Authorized history and growth rate from 2010 to 2024.
  • Galectin Therapeutics Inc Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 150 M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 150 M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 150 M 0 0% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 150 M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 150 M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 150 M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 150 M 0 0% Dec 31, 2022 10-K 2024-03-29
Q3 2022 150 M +50 M +50% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 150 M +50 M +50% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 150 M +50 M +50% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 150 M +50 M +50% Dec 31, 2021 10-K 2023-03-30
Q3 2021 100 M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 100 M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 100 M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 100 M 0 0% Dec 31, 2020 10-K 2022-03-31
Q3 2020 100 M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 100 M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 100 M 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 100 M 0 0% Dec 31, 2019 10-K 2021-03-31
Q3 2019 100 M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 100 M 0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 100 M +50 M +100% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 100 M +50 M +100% Dec 31, 2018 10-K 2020-03-16
Q3 2018 100 M +50 M +100% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 100 M +50 M +100% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 50 M 0 0% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 50 M 0 0% Dec 31, 2017 10-K 2019-03-06
Q3 2017 50 M 0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 50 M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 50 M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 50 M 0 0% Dec 31, 2016 10-K 2018-03-29
Q3 2016 50 M 0 0% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 50 M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 50 M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 50 M 0 0% Dec 31, 2015 10-K 2017-03-28
Q3 2015 50 M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 50 M 0 0% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 50 M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 50 M 0 0% Dec 31, 2014 10-K 2016-03-15
Q3 2014 50 M 0 0% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 50 M 0 0% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 50 M 0 0% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 50 M 0 0% Dec 31, 2013 10-K 2015-03-18
Q3 2013 50 M 0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 50 M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 50 M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 50 M 0 0% Dec 31, 2012 10-K 2014-03-21
Q3 2012 50 M -250 M -83.3% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 50 M -250 M -83.3% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 50 M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 50 M 0 0% Dec 31, 2011 10-K 2013-03-29
Q3 2011 300 M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 300 M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 50 M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.